Registration Options

Activity Dates: 11/04/2021 - 11/04/2024

Session Time and Location

The live session is complete.

Target Audience

If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.

Session Summary

Gain exposure to the rates of depression and anxiety in the patients with opioid use disorder and explore the complicated relationship between managing these co-occurring disorders. You will gain insight into how mental health disparities and stigma associated with opioid use disorder impact the treatment of each individual illness. You will benefit from instruction surrounding the available literature reviewing the treatment of MDD and anxiety in OUD, as well as how the OUD population is often excluded in clinical trials. 

Course Requirements

To receive ACPE credit for this session, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Learning Objectives

  1. Illustrate the relationship between opioid use disorder (OUD) and comorbid depressive and anxiety disorders.
  2. Determine the impact of mental health disparities in accessing co-occurring OUD and depression/anxiety disorder treatment.
  3. Evaluate the available evidence for the treatment of depression and anxiety in patients with co-occurring OUD.
  4. Design a medication regimen for patients with co-occurring OUD and depression or anxiety disorders.

 

Continuing Education Credit and Disclosures

Activity Dates: 11/04/2021 - 11/04/2024
ACPE Contact Hours: 1
ACPE Number: 0284-0000-21-056-H01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.